Differences in gene expression profiles of diabetic and nondiabetic patients undergoing cardiopulmonary bypass and cardioplegic arrest

Circulation

Volumn 110, Issue 11 SUPPL., 2004, Pages

  Voisine, Pierre ^a   Ruel, Marc ^b   Khan, Tanveer A ^a   Bianchi, Cesario ^a   Xu, Shu Hua ^a   Kohane, Isaac ^c   Libermann, Towia A ^a   Otu, Hasan ^a   Saltiel, Alan R ^d   Sellke, Frank W ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardioplegia; Cardiopulmonary bypass; Complications; Diabetes mellitus; Genes

Indexed keywords

AMPHIREGULIN; CYSTEINE RICH PROTEIN 61; FERROPORTIN 1; INTERLEUKIN 1; INTERLEUKIN 6; PROTEIN FOS; PROTEIN SUBUNIT; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CARDIOPULMONARY ARREST; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GLUCOSE METABOLISM; HEART MUSCLE; HEART PROTECTION; HUMAN; IMMUNOBLOTTING; INFLAMMATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN BINDING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECEPTOR GENE; SIGNAL NOISE RATIO; TISSUE SECTION; TRANSCRIPTION INITIATION; UPREGULATION;

ACTINS; AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARDIOPULMONARY BYPASS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HEART ARREST, INDUCED; HUMANS; IMMEDIATE-EARLY PROTEINS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; RISK FACTORS; TRANSCRIPTION, GENETIC;

EID: 4644338086     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000138974.18839.02     Document Type: Article

References (28)

1. Cohen Y, Raz I, Merin G, et al. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Am J Cardiol. 1998;81:7-11.
2. Fietsam RJ, Bassett J, Glover JL. Complications of coronary artery surgery in diabetics. Am Surg. 1991;57:551-557.
3. Luciani N, Nasso G, Gaudino M, et al. Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up. Ann Thorac Surg. 2003;76:1149-1154.
4. Matata BM, Galinanes M. Cardiopulmonary bypass exacerbates oxidative stress but does not increase pro-inflammatory cytokine release in patients with diabetes compared with patients without diabetes: regulatory effects of exogenous nitric oxide. J Thorac Cardiovasc Surg. 2000;120:1-11.
5. Verma S, Maitland A, Weisel RD, et al. Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: reversal by means of endothelin antagonism. J Thorac Cardiovasc Surg. 2002;123:1114-1119.
6. Nawas SI, Doherty JC, Vigneswaran WT, et al. Cardiopulmonary bypass increases coronary IL-8 in diabetic patients without evidence of reperfusion injury. J Surg Res. 1999;84:46-50.
7. Chello M, Mastroroberto P, Cirillo F, et al. Neutrophil-endothelial cell modulations in diabetic patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 1998;14:373-379.
8. Randle PJ. Metabolic fuel selection: general integration at the whole-body level. Proc Nutr Soc. 1995;54:317-327.
9. Rao V, Merante F, Weisel RD, et al. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from stimulated ischemia. J Thorac Cardiovasc Surg. 1998;116:485-494.
10. Lazar HL, Chipkin S, Philippides G, et al. Glucose-insulin-potassium solutions improve outcomes in diabetic patients who have coronary artery operations. Ann Thorac Surg. 2000;70:145-150.
11. Furnary AP, Guangqiang G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
12. Duggan DJ, Bittner M, Chen Y, et al. Expression profiling using cDNA microarrays. Nat Genet. 1999;21:10-14.
13. Ruel M, Bianchi C, Khan TA, et al. Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg. 2003;126:1521-1530.
14. lacobuzio-Donahue CA, Maitra A, Shen-Ong GL, et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol. 2002;160:1239-1249.
15. Haslett JN, Sanoudou D, Kho AT, et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A. 2002;99:15000-15005.
16. Wilcoxon F. Individual comparisons by ranking methods. Biometrics. 1946;1:80-83.
17. Liu WM, Mei R, Di X, et al. Analysis of high-density expression microarrays with signed-rank call algorithms. Bioinformatics. 2002;18:1593-1599.
18. Available from http://www.ncbi.nlm.nih.gov/entrez
19. Hirai S, Sueda T, Orihashi K, et al. Kinetics of pro-inflammatory cytokines release in cardiac surgery with cardiopulmonary bypass. Jpn J Thorac Cardiovasc Surg. 2001;49:216-219.
20. Kido Y, Nakae J, Accili D. The insulin receptor and its cellular targets. J Clin Endocrinol Metab. 2001;86:972-979.
21. Matata B, Galinanes M. Effect of diabetes on nitric oxide metabolism during cardiac surgery. Diabetes. 2001;50:2603-2610.
22. White MF, Maron R, Khan CR. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature. 1985;318:183-186.
23. Newgard CB, Brady MJ, O'Doherty RM, et al. Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein-phosphatase-1. Diabetes. 2000;49:1967-1977.
24. King HC, Sinha AA. Gene expression profile analysis by DNA microarrays: promise and pitfalls. JAMA. 2001;286:2280-2288.
25. Sterling MC, McClanahan TB, Schott RJ, et al. Distribution of cardioplegic solution infused antegradely and retrogradely in normal canine hearts. J Thorac Cardiovasc Surg. 1989;98:1066-1076.
26. Gorza L, Mercadier JJ, Schwartz K, et al. Myosin types in the human heart. An immunofluorescence study of normal and hypertrophied atrial and ventricular myocardium. Circ Res. 1984;54:694-702.
27. Hoffmann U, Axmann C, Grisk A. Myosin isoenzymes in normal and hypertrophied human hearts. Biomed Biochim Acta. 1986;45:985-996.
28. Araujo EG, Bianchi C, Sato K, et al. Inactivation of the MEK/ERK pathway in the myocardium during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001;121:773-781.